Clinical Update on RAS Targeting In CRC

Time: 2:30 pm
day: Day Two Track F


  • Multiple clinical trials are ongoing in CRC to explore the efficacy of RAS targeting, with varying degrees of effica
  • Mechanisms of adaptive resistance are prevalent, and preclinical studies can guide rational combinations
  • Based on experience to date, combinations will be needed in most settings for CRC patients